IRCT20150630022991N11RecruitingPhase 4
Efficacy of Sertraline on the Symptoms and Quality of Life in Irritable Bowel Syndrome Patients
Conditions
Trial Snapshot
- Phase
- Phase 4
- Status
- Recruiting
- Enrollment
- 60
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 18 years to no limit (—)
- Sex
- All
Inclusion Criteria
- •The presence of ROME III diagnostic criteria for the diagnosis of irritable bowel syndrome
- •Written consent for participation in the study
Exclusion Criteria
- •Age under 18 years
- •Allergy to sertraline
- •The presence of warning signs such as chronic fever, weight loss, gastrointestinal bleeding
- •Pregnancy and breast feeding
- •Use of any drug that affects the bowel function (such as laxatives, anti diarrhea and antibiotics) within one month before entering the study
- •Known cases of lactose intolerance
- •Comorbidity of other serious physical or psychological illnesses, serious suicidal thoughts and substance dependence that affect the treatment of patients and their compliance with the study protocol
Investigators
Similar Trials
Completed
Not Applicable
The Effectiveness of Medical Treatment on Executive Performance of Patients suffering from Obsessive Compulsive DisorderIRCT2017100826138N1Deputy of Research of Ardabil University of Medical Sciences30
Completed
Not Applicable
sertraline effect on strokeStroke.Stroke, not specified as haemorrhage or infarctionIRCT2012101011062N1Tabriz University of medical sciences, Vice chancellor of research80
Not yet recruiting
Phase 2
Comparison of the effect of sertraline and midodrine in improving blood pressure during hemodialysisHypotension of hemodialysis.Hypotension of hemodialysisI95.3IRCT20100102002954N29Shahroud University of Medical Sciences82
Completed
Phase 3
Sertraline and Fluoxetin in Diabetic Patients with DepressioDiabetes Mellitus.Diabetes mellitus due to underlying conditionIRCT20150630022991N9Babol University of Medical Sciences40
Recruiting
Phase 2
Evaluation of effectiveness of Sertraline and supportive psychotherapy on anxiety and depression levelIRCT20180425039418N4Zahedan University of Medical Sciences60
